International Workshop on the role of biological monitoring in the prevention of aluminium toxicity in man: "Aluminium Analysis in Biological Fluids," Luxembourg, July 5-7, 1982. Memorandum on the summary and conclusions. - Suppr | 超能文献

International Workshop on the role of biological monitoring in the prevention of aluminium toxicity in man: "Aluminium Analysis in Biological Fluids," Luxembourg, July 5-7, 1982. Memorandum on the summary and conclusions.

出版信息

J Toxicol Clin Toxicol. 1982 Oct;19(8):907-10. doi: 10.3109/15563658208992524.

DOI:10.3109/15563658208992524

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

International Workshop on the role of biological monitoring in the prevention of aluminium toxicity in man: "Aluminium Analysis in Biological Fluids," Luxembourg, July 5-7, 1982. Memorandum on the summary and conclusions.

J Toxicol Clin Toxicol. 1982 Oct;19(8):907-10. doi: 10.3109/15563658208992524.

2

Critical concentrations of aluminium in water used for dialysis.用于透析的水中铝的临界浓度。

Lancet. 1981 Oct 10;2(8250):802-3. doi: 10.1016/s0140-6736(81)90203-8.

3

Silicon and aluminium interactions in haemodialysis patients.血液透析患者中硅与铝的相互作用

Nephrol Dial Transplant. 1998 Jul;13(7):1759-62. doi: 10.1093/ndt/13.7.1759.

4

Aluminium toxicity during regular haemodialysis.常规血液透析期间的铝中毒

Br Med J. 1978 Apr 29;1(6120):1101-3. doi: 10.1136/bmj.1.6120.1101.

5

Aluminium studies in dialysis encephalopathy.透析性脑病中的铝研究。

Proc Eur Dial Transplant Assoc. 1978;15:157-63.

6

The effect of oral aluminium therapy on plasma aluminium levels in patients with chronic renal failure in an area with low water aluminium.在低水铝地区，口服铝剂治疗对慢性肾衰竭患者血浆铝水平的影响。

Clin Nephrol. 1982 May;17(5):222-7.

7

Serum and dialysate aluminium concentration of dialysed patients with chronic renal failure determined by atomic absorption spectrometry with a graphite furnace.用石墨炉原子吸收光谱法测定慢性肾衰竭透析患者的血清和透析液铝浓度。

Clin Chim Acta. 1985 Apr 30;147(3):247-54. doi: 10.1016/0009-8981(85)90206-2.

8

Fracturing dialysis osteodystrophy and dialysis encephalopathy. An epidemiological survey.

Lancet. 1979 Feb 24;1(8113):406-9. doi: 10.1016/s0140-6736(79)90883-3.

9

Reversal of aluminium dialysis encephalopathy after desferrioxamine treatment.去铁胺治疗后铝透析脑病的逆转

Lancet. 1981 Nov 14;2(8255):1116. doi: 10.1016/s0140-6736(81)91324-6.

10

Low aluminium water, desferrioxamine, and dialysis encephalopathy.低铝水、去铁胺与透析性脑病

Lancet. 1982 Aug 28;2(8296):502. doi: 10.1016/s0140-6736(82)90535-9.

引用本文的文献

1

Behaviour of plasma and urinary aluminium levels in occupationally exposed subjects.职业暴露人群血浆和尿铝水平的变化情况

Int Arch Occup Environ Health. 1984;54(2):155-61. doi: 10.1007/BF00378518.

2

Prophylactic aluminium hydroxide and hyperaluminaemia in intensive care.重症监护中的预防性氢氧化铝与高铝血症

Intensive Care Med. 1987;13(4):293-4. doi: 10.1007/BF00265122.

3

Determination of aluminum by neutron activation analysis in human lung tissue and in chemicals for dialysis of uremic patients.通过中子活化分析法测定人肺组织以及尿毒症患者透析用化学物质中的铝含量。

Biol Trace Elem Res. 1988 Sep-Dec;17:271-84. doi: 10.1007/BF02795463.